Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/rheumatology/kead479 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Overcoming anti-Infliximab antibodies and maintaining Infliximab achieves superior durability and outcome compared to switching to Adalimumab.
Dig Liver Dis
September 2025
Division of Pediatric Gastroenterology and Nutrition, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Israel; The Gray Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel; Cincinnati Children's Hospital Medical Center and the University of Cin
Background And Aims: The development of antibodies to infliximab (ATI) is a major challenge in pediatric inflammatory bowel disease (IBD). This real-world study aimed to identify predictors of ATI, evaluate strategies to overcome ATI, and compare the durability of continuing infliximab (IFX) versus switching to adalimumab (ADA) after ATI development.
Methods: We retrospectively analyzed 194 pediatric IBD patients treated with IFX from 2010 to 2024.
Polypill in heart failure: a pathway to simplified treatment and improved adherence and outcomes.
Heart Fail Rev
September 2025
Department of Medicine, Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Canada.
Heart failure (HF) remains a global health challenge that imposes significant clinical and economic burden. Treatment adherence to guideline-directed medical therapy (GDMT) remains a major challenge in the management of HF, despite the availability of guideline-directed medical therapy (GDMT). Polypharmacy and regimen complexity contribute to poor adherence, particularly among older adults and in resource-limited settings.
View Article and Find Full Text PDFCone-Shaped Constrained Quasi-Newton Method: Efficient and Robust Single-Ended Transition State Optimization Algorithm.
J Chem Theory Comput
September 2025
State Key Laboratory of Green Chemical Engineering and Industrial Catalysis, Center for Computational Chemistry and Research Institute of Industrial Catalysis, East China University of Science and Technology, Shanghai 200237, People's Republic of China.
Efficient transition state location is a central challenge in heterogeneous catalysis. While single-ended methods are more efficient than double-ended methods, their convergence is often highly sensitive to the quality of the initial guess. Here, we propose a Cone-shaped Constrained Quasi-Newton (CCQN) method, which introduces a cone-shaped constraint to restrict the search direction, thereby effectively guiding the system from potential well regions toward saddle regions.
View Article and Find Full Text PDFEfficacy and safety of biosimilars in gastroenterology: a focus on inflammatory bowel disease management.
Expert Opin Biol Ther
September 2025
Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
Introduction: The introduction of biosimilars changed the management of biologicals in inflammatory bowel disease (IBD) since the approval of CT-P13, the first biosimilar to infliximab, by the European Medicines Agency (EMA) in September 2013 and by the U.S. Food and Drug Administration (FDA) in April 2016.
View Article and Find Full Text PDFHistological evaluations of a series of socket preservation procedures using tooth as graft material.
Eur Rev Med Pharmacol Sci
August 2025
Private Practice.
Unlabelled: OBJECTIVE: In this multicenter study, we assessed the effectiveness of a novel autologous bone substitute obtained directly from the processing of extracted teeth. A total of 34 consecutive tooth grafting procedures were performed. MATERIALS AND METHODS: Immediately following atraumatic extraction for restorative or endodontic purposes, the bone defect was filled and covered with an Osseoguard© membrane, using autologous material derived from the extracted tooth.
View Article and Find Full Text PDF